DAVID PROPST: Open Payments
NPI 1881823896 · LENOIR, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$360 in 17 payments from 13 companies in 2025. Trend: 2023 $33 · 2024 $91 · 2025 $360
Food & beverage: $360
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Madrigal Pharmaceuticals | 1 | $25 |
| Verona Pharma, Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Grifols USA, LLC | 1 | $22 |
| Intercept Pharmaceuticals, Inc. | 1 | $20 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
Products named: DUPIXENT, CAPLYTA, FARXIGA, AIRSUPRA, TRELEGY ELLIPTA, REZDIFFRA, Ohtuvayre, Kerendia.
Industry payments across NC — which companies pay providers there.
